REcycled CartiLage Auto/Allo IMplantation

Summary

This is an FDA phase I study to evaluate the safety of allogeneic culture-expanded adipose-derived mesenchymal stem cells (AMSCs) combined with autologous cartilage cells to treat focal knee cartilage defects in one stage surgery.

Timeline

Start

2018-09-13

Primary completion

2024-05-09

Completion

2024-06-21

Drugs

Indications